By Business/Source
Currency:CNY
2025/Q2
Stock NameRevenueRatio
In-hospital channel62.5M42.07%
Pharma research and development channel45.2M30.42%
Central laboratory channel40.86M27.51%
By Country/Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
People’s Republic of China (PRC)510.24M98.92%
United States5.58M1.08%